Anika Therapeutics, Inc. (ANIK)
NASDAQ: ANIK · Real-Time Price · USD
21.42
+1.26 (6.25%)
Aug 7, 2026, 4:00 PM EDT - Market closed
Anika Therapeutics Market Cap
Anika Therapeutics has a market cap or net worth of $286.66 million as of August 7, 2026. Its market cap has increased by 141.10% in one year.
Market Cap
286.66M
Enterprise Value
273.50M
1-Year Change
141.10%
Ranking
Category
Stock Price
$21.42
ChartMarket Cap Chart
Since December 1, 1998, Anika Therapeutics's market cap has increased from $51.20M to $286.66M, an increase of 459.89%. That is a compound annual growth rate of 6.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 286.70M | 106.85% |
| Dec 31, 2025 | 138.60M | -42.51% |
| Dec 31, 2024 | 241.10M | -27.34% |
| Dec 29, 2023 | 331.80M | -23.27% |
| Dec 30, 2022 | 432.40M | -16.41% |
| Dec 31, 2021 | 517.30M | -19.59% |
| Dec 31, 2020 | 643.30M | -13.06% |
| Dec 31, 2019 | 739.90M | 54.92% |
| Dec 31, 2018 | 477.60M | -39.57% |
| Dec 29, 2017 | 790.40M | 10.39% |
| Dec 30, 2016 | 716.00M | 28.18% |
| Dec 31, 2015 | 558.60M | -5.47% |
| Dec 31, 2014 | 590.90M | 12.00% |
| Dec 31, 2013 | 527.60M | 284.27% |
| Dec 31, 2012 | 137.30M | 2.85% |
| Dec 30, 2011 | 133.50M | 48.50% |
| Dec 31, 2010 | 89.90M | 2.98% |
| Dec 31, 2009 | 87.30M | 152.31% |
| Dec 31, 2008 | 34.60M | -78.71% |
| Dec 31, 2007 | 162.50M | 14.12% |
| Dec 29, 2006 | 142.40M | 16.06% |
| Dec 30, 2005 | 122.70M | 31.51% |
| Dec 31, 2004 | 93.30M | -4.11% |
| Dec 31, 2003 | 97.30M | 892.86% |
| Dec 31, 2002 | 9.80M | -1.01% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aquestive Therapeutics | 494.34M |
| Kamada | 412.18M |
| Canopy Growth | 400.11M |
| Alpha Teknova | 346.35M |
| Akebia Therapeutics | 252.14M |
| Emergent BioSolutions | 248.29M |
| Organogenesis Holdings | 239.33M |
| SIGA Technologies | 218.76M |